Why the study?
Do pharmacological inhibitors (ACE inhibitors, alpha-1 blockers, AT1 receptor blockers) prevent ventricular remodeling in a canine model of myocardial injury?
Population
Canine model of localized myocardial injury resulting from transmyocardial DC shock
Comparison
Zofenopril, terazosin, full-dose ramipril… vs Control group
Design
Preclinical
Follow-up
16 weeks
Authors
Loading...
Zofenopril attenuated post-injury remodeling in this canine model; hypothesis-generating for human ventricular remodeling prevention.
Do pharmacological inhibitors (ACE inhibitors, alpha-1 blockers, AT1 receptor blockers) prevent ventricular remodeling in a canine model of myocardial injury?
High-dose ACE inhibitor therapy prevents progressive structural changes after localized myocardial damage in a canine model, whereas alpha-1 adrenoceptor blockade and AT1 receptor blockade do not.
McDonald et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: